Patient costs associated with accessing HIV/AIDS care in Malawi.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3604364)

Published in J Int AIDS Soc on March 19, 2013

Authors

Andrew D Pinto1, Monique van Lettow, Beth Rachlis, Adrienne K Chan, Sumeet K Sodhi

Author Affiliations

1: Department of Family and Community Medicine, St. Michael's Hospital, Toronto, Canada. andrew.pinto@utoronto.ca

Articles cited by this

Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med (2011) 11.05

How should cost data in pragmatic randomised trials be analysed? BMJ (2000) 6.66

Scaling up antiretroviral treatment in resource-poor settings. Lancet (2006) 5.51

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med (2000) 4.81

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ (1997) 4.43

Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi. Int J Tuberc Lung Dis (2005) 4.04

Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One (2006) 3.26

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health (2008) 3.16

Increasing uptake of HIV testing and counseling among the poorest in sub-Saharan countries through home-based service provision. J Acquir Immune Defic Syndr (2009) 2.79

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health (2005) 2.68

Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ (2004) 2.33

Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg (2009) 2.27

Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health (2010) 2.19

Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health (2010) 2.00

Costs of scaling up health interventions: a systematic review. Health Policy Plan (2005) 1.92

Malawi's contribution to "3 by 5": achievements and challenges. Bull World Health Organ (2007) 1.89

A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006. J Acquir Immune Defic Syndr (2008) 1.81

Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J (2007) 1.77

Accounting for the cost of scaling-up health interventions. Health Econ (2004) 1.67

Who has access to counseling and testing and anti-retroviral therapy in Malawi - an equity analysis. Int J Equity Health (2009) 1.37

Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc (2011) 1.22

Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights. BMC Pediatr (2009) 1.17

Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg (2010) 1.05

Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings. AIDS Care (2009) 0.97

Estimating the cost of care giving on caregivers for people living with HIV and AIDS in Botswana: a cross-sectional study. J Int AIDS Soc (2010) 0.95

Optimisation of HIV care and service delivery: doing more with less. Lancet (2012) 0.87

Who accesses antiretroviral drugs within public sector in Malawi? Croat Med J (2006) 0.79

Stretching the AIDS dollar. Lancet (2009) 0.77

Articles by these authors

Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol (2006) 4.32

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. N Engl J Med (2016) 3.59

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol (2008) 3.33

Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health (2010) 2.19

Barriers to participating in an HIV vaccine trial: a systematic review. AIDS (2004) 1.97

Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis (2003) 1.76

Uptake and outcomes of a prevention-of mother-to-child transmission (PMTCT) program in Zomba district, Malawi. BMC Public Health (2011) 1.63

Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens. AIDS (2008) 1.55

Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLoS One (2012) 1.48

Metastatic renal cell cancer treatments: an indirect comparison meta-analysis. BMC Cancer (2009) 1.37

HIV/AIDS in African militaries: an ecological analysis. Med Confl Surviv (2008) 1.34

Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi). J Acquir Immune Defic Syndr (2014) 1.26

Anti-retroviral treatment outcomes among older adults in Zomba district, Malawi. PLoS One (2011) 1.18

Barriers to participation in HIV drug trials: a systematic review. Lancet Infect Dis (2006) 1.17

Media reporting of tenofovir trials in Cambodia and Cameroon. BMC Int Health Hum Rights (2005) 1.15

Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med (2009) 1.15

The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res (2014) 1.08

The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]. BMC Clin Pharmacol (2003) 1.05

Mortality and health outcomes in HIV-infected and HIV-uninfected mothers at 18-20 months postpartum in Zomba District, Malawi. PLoS One (2012) 0.98

Women's choices regarding HIV testing, disclosure and partner involvement in infant feeding and care in a rural district of Malawi with high HIV prevalence. AIDS Care (2013) 0.96

Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax (2007) 0.96

High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi. PLoS One (2012) 0.95

Involving expert patients in antiretroviral treatment provision in a tertiary referral hospital HIV clinic in Malawi. BMC Health Serv Res (2012) 0.93

Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi. PLoS One (2012) 0.93

Building a national direction for research in the prevention of mother to child transmission of HIV: results from a national prioritization initiative in Malawi. Health Res Policy Syst (2013) 0.91

CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial. Trials (2014) 0.89

Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi). J Acquir Immune Defic Syndr (2017) 0.87

Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Eur J Clin Pharmacol (2005) 0.86

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis. Clin Ophthalmol (2009) 0.86

Using concept mapping to explore why patients become lost to follow up from an antiretroviral therapy program in the Zomba District of Malawi. BMC Health Serv Res (2013) 0.84

Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials (2008) 0.81

Randomized trials stopped early for harm in HIV/AIDS: a systematic survey. HIV Clin Trials (2006) 0.80

Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience. J Acquir Immune Defic Syndr (2016) 0.80

Possible infectious causes of spontaneous splenic rupture: a case report. J Med Case Rep (2014) 0.80

Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi. J Acquir Immune Defic Syndr (2016) 0.77

Outcome assessment of a dedicated HIV positive health care worker clinic at a central hospital in Malawi: a retrospective observational study. PLoS One (2011) 0.76

Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study. J Acquir Immune Defic Syndr (2017) 0.75